Nabumetone
Product Images NDC 54868-4556

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Nabumetone (NDC 54868-4556). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Of 500 mg Package Label (4556)

Label for NABUMETONE 500 mg tablets by Physicians Total Care, Inc. The package contains 30 tablets. The label includes caution about federal law prohibiting dispensing without prescription, storage instructions, lot number, expiration date, and barcode.*

FDA Label Image

Image Of 750 mg Package Label (4558)

NABUMETONE 750 MG tablet bottle label from Physicians Total Care, Inc. The label indicates each tablet contains 750 mg of nabumetone and that the bottle contains 30 tablets. It includes cautionary text regarding prescription requirements, storage instructions, lot number, expiration date, and a barcode.*

FDA Label Image

Structural Formula Of Nabumetone (87028b13 0aab 4e90 B92e 6b0c54e59bbb 01)

Chemical structure of nabumetone, showing its molecular framework with rings, a methoxy group, and a ketone functional group. The formula C15H16O2 and molecular weight 228.3 are indicated.*

FDA Label Image

6mna (87028b13 0aab 4e90 B92e 6b0c54e59bbb 02)

Chemical structure diagram of 6-methoxy-2-naphthylacetic acid (6MNA), the active metabolite of Nabumetone. The diagram shows a naphthalene ring with a methoxy group and a carboxylic acid side chain.*

FDA Label Image

Table 1 (87028b13 0aab 4e90 B92e 6b0c54e59bbb 03)

A data table showing pharmacokinetic parameters with means and standard deviations for young adults and elderly groups at dosages of 1,000 mg and 2,000 mg. Parameters include Tmax (hr), t1/2 (hr), CLss/F (mL/min), and Vdss/F (L) for each group.*

FDA Label Image

6mna Plasma Concentrations (87028b13 0aab 4e90 B92e 6b0c54e59bbb 04)

A pharmacokinetic graph illustrating Nabumetone active metabolite (6MNA) plasma concentrations at steady state over 70 hours after once-daily dosing of 1000 mg and 2000 mg in human participants. The y-axis shows concentration in mcg/mL, and the x-axis shows time in hours. The graph includes mean concentrations and standard deviation ranges (-2 SD and +2 SD) for both dosage levels.*

FDA Label Image

Metabolites (87028b13 0aab 4e90 B92e 6b0c54e59bbb 05)

A data table presenting the percentages of various nabumetone metabolites detected in a dose, including unchanged nabumetone, 6-methoxy-2-naphthylacetic acid (6MNA), 6MNA conjugated, 6-hydroxy-2-naphthylacetic acid (6HNA) unchanged and conjugated, 4-(6-hydroxy-2-naphthyl)-butan-2-ol conjugated, O-desmethyl-nabumetone conjugated, and unidentified minor metabolites. The total percentage of the dose accounted for is 73%.*

FDA Label Image

Table 2 (87028b13 0aab 4e90 B92e 6b0c54e59bbb 06)

A data table showing the number of patients with osteoarthritis (OA) and rheumatoid arthritis (RA) treated with various doses of Nabumetone (500 mg, 1,000 mg, 1,500 mg, 2,000 mg), along with the mean and mode duration of treatment in years for each dose and condition.*

FDA Label Image

Side Effects Table (87028b13 0aab 4e90 B92e 6b0c54e59bbb 07)

Drug facts panel listing serious and other side effects of Nabumetone. Serious side effects include heart attack, stroke, high blood pressure, heart failure from fluid retention, kidney problems, bleeding and ulcers in stomach and intestine, anemia, life-threatening skin and allergic reactions, liver failure, and asthma attacks. Other side effects include stomach pain, constipation, diarrhea, gas, heartburn, nausea, vomiting, and dizziness.*

FDA Label Image

Get Emergency Help If You Experience These Symptoms (87028b13 0aab 4e90 B92e 6b0c54e59bbb 08)

A text panel listing symptoms such as shortness of breath or trouble breathing, chest pain, weakness in one part or side of the body, slurred speech, and swelling of the face or throat. The text is organized in two columns with bullet points.*

FDA Label Image

Stop Nsaid If You Experience These Symptoms (87028b13 0aab 4e90 B92e 6b0c54e59bbb 09)

A drug facts or warning information panel listing symptoms such as nausea, fatigue, itching, jaundice, stomach pain, flu-like symptoms, vomiting blood, blood in bowel movements, unusual weight gain, skin rash with fever, and swelling of extremities that may be associated with the medication Nabumetone from Physicians Total Care, Inc.*

FDA Label Image

Nsaid Medications That Need A Prescription (87028b13 0aab 4e90 B92e 6b0c54e59bbb 10)

A table listing generic drug names and their corresponding tradenames, including Nabumetone with the tradename Relafen. The table also includes other NSAIDs such as Celecoxib (Celebrex), Diclofenac (Cataflam, Voltaren, Arthrotec), Ibuprofen (Motrin, Tab-Profen, Vicoprofen, Combunox), and Naproxen (Naprosyn, Anaprox, Naprelan), among others.*

FDA Label Image

Glenmark Logo (87028b13 0aab 4e90 B92e 6b0c54e59bbb 11)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.